$NUVB

$4.51 -$0.06 (1.31%) Close

$NUVB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NUVB Management Team

Dr. David Hung

Chairman of the Board

President

Chief Executive Officer

Founder

Age 67

Compensation $3.717M USD

Sex Male

Mr. Joe Rayne

Investor Relations

Age -

Compensation -

Sex Male

Mr. David Hanley

Chief Technical Operations Officer

Age 55

Compensation $3.307M USD

Sex Male

Ms. Stacy Markel

Chief People Officer

Age 60

Compensation -

Sex Female

Mr. Moses Makunje

Principal Accounting Officer

Vice President - Finance

Age 47

Compensation -

Sex Male

Dr. Gary Hattersley

Chief Scientific Officer

Age 58

Compensation $1.407M USD

Sex Male

Mr. David Liu

Chief Medical Officer

Age 55

Compensation $1.342M USD

Sex Male

Ms. Kerry Wentworth

Chief Regulatory Officer

Age 52

Compensation -

Sex Female

Mr. Philippe Sauvage

Chief Financial Officer and Principal Financial Officer

Age 48

Compensation -

Sex Male

Ms. Colleen Sjogren

Chief Commercial Officer

Age 55

Compensation $2.173M USD

Sex Female

Name / Title	Age	Compensation	Sex
Dr. David Hung Chairman of the Board President Chief Executive Officer Founder	67	$3.717M USD	Male
Mr. Joe Rayne Investor Relations	-	-	Male
Mr. David Hanley Chief Technical Operations Officer	55	$3.307M USD	Male
Ms. Stacy Markel Chief People Officer	60	-	Female
Mr. Moses Makunje Principal Accounting Officer Vice President - Finance	47	-	Male
Dr. Gary Hattersley Chief Scientific Officer	58	$1.407M USD	Male
Mr. David Liu Chief Medical Officer	55	$1.342M USD	Male
Ms. Kerry Wentworth Chief Regulatory Officer	52	-	Female
Mr. Philippe Sauvage Chief Financial Officer and Principal Financial Officer	48	-	Male
Ms. Colleen Sjogren Chief Commercial Officer	55	$2.173M USD	Female

Board of Directors

From the proxy statement filed Apr 10, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 1 not stated

Average tenure

5.4 years

from year joined

CEO also chairs the board

Yes

David Hung, M.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Robert B. Bazemore, Jr. Lead independent director	58	2020 6 years	Independent	None stated	Ardelyx, Inc., Akari Therapeutics, Plc	$483,000
Kim Blickenstaff	73	2019 7 years	Independent	audit	None stated	$436,250
Robert Mashal, M.D.	67	2024 2 years	Independent	nominating and corporate governance	None stated	$422,500
Min Cui, Ph.D.	57	2024 2 years	Independent	compensation	None stated	Not stated
W. Anthony Vernon	70	2019 7 years	Independent	compensation · Chair	NovoCure Ltd.	$446,000
Kathryn E. Falberg	66	2020 6 years	Independent	audit · Chair	Arcus Biosciences, Inc., The Trade Desk, Inc.	$445,000
David Hung, M.D. Board chair, CEO	68	2018 8 years	Not stated	None stated	NovoCure Ltd.	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 10, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$NUVB Management Team

Dr. David Hung

Mr. Joe Rayne

Mr. David Hanley

Ms. Stacy Markel

Mr. Moses Makunje

Dr. Gary Hattersley

Mr. David Liu

Ms. Kerry Wentworth

Mr. Philippe Sauvage

Ms. Colleen Sjogren

Board of Directors

Related-party transactions

No related-party transactions disclosed